Live
Clinical OMICsPaper Mills and the Fight Against Scientific FraudClinical OMICsNanowire Device Captures EVs for Targeted Cancer Liquid BiopsiesCellComplete biosynthesis of the anticancer cephalotaxinone and homoerythratineEndpoints NewsAmgen and the FDA want two different outcomes for Tavneos. What will patients do?Endpoints NewsEli Lilly invests in startup Abridge for clinical trial recruitmentBioWorldMoney raised by biopharmaBioWorldBiopharma money raised: Jan. 1-June 11, 2026Thermo FisherThermo Fisher Tests SpheriCal Calibration As Potential Edge In Mass Spectrometry - Yahoo FinanceLonza NewsAmMax Bio licenses antibody-drug conjugate technology for haematological cancers from Lonza - Manufacturing ChemistFierceBiotech‘I wouldn’t call it a blip’: Biotech IPOs here to stay after another record-breaking listingBioWorldIn the clinic for June 12, 2026BioWorldOther news to note for June 12, 2026
Abbott Apr 25, 2026

4 new studies test Abbott devices for irregular heartbeats - Stock Titan

4 new studies test Abbott devices for irregular heartbeats - Stock Titan

Body unavailable. Use the original source.